PT1094807E - Vitamina e e esters para uso em tratamento local de patologias mucosas - Google Patents

Vitamina e e esters para uso em tratamento local de patologias mucosas

Info

Publication number
PT1094807E
PT1094807E PT99926687T PT99926687T PT1094807E PT 1094807 E PT1094807 E PT 1094807E PT 99926687 T PT99926687 T PT 99926687T PT 99926687 T PT99926687 T PT 99926687T PT 1094807 E PT1094807 E PT 1094807E
Authority
PT
Portugal
Prior art keywords
vitamin
vulvitis
esters
pathologies
mucous
Prior art date
Application number
PT99926687T
Other languages
English (en)
Portuguese (pt)
Inventor
Giorgio Panin
Eleonora Annunziata
Original Assignee
Bio Lo Ga Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11380415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1094807(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bio Lo Ga Srl filed Critical Bio Lo Ga Srl
Publication of PT1094807E publication Critical patent/PT1094807E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Gynecology & Obstetrics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT99926687T 1998-07-10 1999-07-05 Vitamina e e esters para uso em tratamento local de patologias mucosas PT1094807E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT98MI001586A ITMI981586A1 (it) 1998-07-10 1998-07-10 Vitamina e e suoi esteri per l'uso nel trattamento topico di patologie delle mucose

Publications (1)

Publication Number Publication Date
PT1094807E true PT1094807E (pt) 2003-08-29

Family

ID=11380415

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99926687T PT1094807E (pt) 1998-07-10 1999-07-05 Vitamina e e esters para uso em tratamento local de patologias mucosas

Country Status (22)

Country Link
EP (1) EP1094807B1 (https=)
JP (1) JP2002520281A (https=)
CN (1) CN1135975C (https=)
AT (1) ATE238051T1 (https=)
AU (1) AU762860B2 (https=)
BR (1) BR9911945A (https=)
CA (1) CA2336990A1 (https=)
CZ (1) CZ301019B6 (https=)
DE (1) DE69907193T2 (https=)
DK (1) DK1094807T3 (https=)
ES (1) ES2196813T3 (https=)
HU (1) HU228921B1 (https=)
IL (1) IL140759A0 (https=)
IT (1) ITMI981586A1 (https=)
NO (1) NO20006719L (https=)
NZ (1) NZ509129A (https=)
PL (1) PL345500A1 (https=)
PT (1) PT1094807E (https=)
RU (2) RU2221561C2 (https=)
SK (1) SK284464B6 (https=)
TR (2) TR200103710T2 (https=)
WO (1) WO2000002554A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077604A1 (en) 2001-12-19 2004-04-22 Lenard Lichtenberger Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providingenhanced therapeutic activity
FR2819186A1 (fr) * 2001-01-10 2002-07-12 L M D Cystine-voie orale-syndrome de l'oeil sec
FR2825088A1 (fr) * 2001-05-25 2002-11-29 Derma Dev Nouveaux esters de tocopherol, leurs procedes d'obtention et leurs utilisations
US7485666B2 (en) * 2004-06-17 2009-02-03 Kimberly-Clark Worldwide, Inc. Vaginal health products
US8541413B2 (en) * 2004-10-01 2013-09-24 Ramscor, Inc. Sustained release eye drop formulations
US9993558B2 (en) 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
US20080038316A1 (en) 2004-10-01 2008-02-14 Wong Vernon G Conveniently implantable sustained release drug compositions
AU2006220248B2 (en) * 2005-03-03 2012-06-21 Vital Health Sciences Pty Ltd Compounds having lipid lowering properties
BRPI0920326A2 (pt) * 2008-10-09 2016-02-23 Ramscor Inc composição e método para tratamento da síndrome do olho ressecado
IT1394063B1 (it) * 2009-05-11 2012-05-25 Giuliani Spa Composizione per uso oftalmico adatta al trattamento degli stati infiammatori dell'occhio e della sindrome dell'occhio secco
US9192594B2 (en) * 2009-07-27 2015-11-24 Renato Sanseverino Ophthalmic solution for protecting internal structures of the eyeball against UV-A rays or for the treatment of keratoconus with a trans-epithelial cross-linking technique
CN103957888B (zh) 2011-09-29 2017-11-21 PLx 制药公司 用于将药物沿胃肠道靶向释放的pH依赖性载体、其组合物及其制备和应用
WO2013185024A1 (en) * 2012-06-08 2013-12-12 The Ohio State University Treating burn and scar injury using tocotrienol
DE202014106007U1 (de) * 2014-07-22 2015-07-23 Bio.Lo.Ga. S.R.L. Zusammensetzung zur Verwendung in der Vorbeugung und Behandlung allergischer Rhinitis
CN107438429A (zh) * 2014-10-22 2017-12-05 拜洛嘉有限责任公司 用于增加鼻粘膜的营养作用的药物组合物
JP2018507895A (ja) 2015-03-18 2018-03-22 バイオヌークス スイス エスエー ヘルペスを処置するための方法において使用するためのジヒドロケルセチンを含む組成物
JP2017119669A (ja) * 2015-10-15 2017-07-06 ロート製薬株式会社 異物感改善用眼科組成物
EP3849514A1 (en) * 2018-09-12 2021-07-21 Neilos S.r.l. A composition for use in the prevention and/or treatment of epistaxis
IT202000003620A1 (it) * 2020-02-21 2021-08-21 Hulka S R L Uso di una formulazione per applicazione topica per il mantenimento dell’omeostasi vaginale
AU2021244695A1 (en) 2020-03-26 2022-11-10 Plx Opco Inc. Pharmaceutical carriers capable of pH dependent reconstitution and methods for making and using same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59216812A (ja) * 1983-05-26 1984-12-06 Dowa Yakushiyou Kk 頭髪育毛料
JP2776837B2 (ja) * 1988-08-11 1998-07-16 日本レダリー株式会社 消化性潰瘍治療剤
US5032384A (en) * 1989-01-27 1991-07-16 Block Drug Company, Inc. Compositions and method for the treatment of disease
SU1628281A3 (ru) * 1989-03-30 1994-02-28 Научно-производственная фирма "Флори" Ранозаживляющее средство
IT1249711B (it) * 1991-09-30 1995-03-09 Boniscontro E Gazzone S R L Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici,indicate nella terapia dei tessuti superficiali.
JP2811036B2 (ja) * 1992-05-26 1998-10-15 参天製薬株式会社 ビタミンe点眼剤
JP3551977B2 (ja) * 1993-04-08 2004-08-11 ライオン株式会社 安定なビタミンa類及びビタミンe類可溶化点眼剤
CN1039087C (zh) * 1993-12-29 1998-07-15 昆明宏达实业有限总公司 妇科病治疗保健外用药物
RU2125887C1 (ru) * 1995-08-25 1999-02-10 Владивостокский государственный медицинский университет Способ приготовления липосомального интерферона
IT1282778B1 (it) * 1996-05-31 1998-03-31 Giorgio Panin Vitamina "e" acetato quale prodotto per applicazione topica
JPH10109934A (ja) * 1996-10-04 1998-04-28 Sekisui Chem Co Ltd 炎症性眼疾患用剤
JPH10231243A (ja) * 1997-02-20 1998-09-02 Sekisui Chem Co Ltd 粘膜炎症外用薬

Also Published As

Publication number Publication date
WO2000002554A1 (en) 2000-01-20
AU4385899A (en) 2000-02-01
CN1135975C (zh) 2004-01-28
CZ301019B6 (cs) 2009-10-14
DE69907193D1 (de) 2003-05-28
CZ200136A3 (cs) 2001-08-15
ATE238051T1 (de) 2003-05-15
HU228921B1 (en) 2013-06-28
CN1308531A (zh) 2001-08-15
NO20006719D0 (no) 2000-12-29
AU762860B2 (en) 2003-07-10
JP2002520281A (ja) 2002-07-09
TR200103710T2 (tr) 2002-06-21
TR200100014T2 (tr) 2001-06-21
RU2221561C2 (ru) 2004-01-20
NO20006719L (no) 2001-02-16
DE69907193T2 (de) 2004-04-08
ES2196813T3 (es) 2003-12-16
NZ509129A (en) 2003-10-31
SK352001A3 (en) 2001-06-11
EP1094807A1 (en) 2001-05-02
DK1094807T3 (da) 2003-08-11
IL140759A0 (en) 2002-02-10
PL345500A1 (en) 2001-12-17
HUP0102781A2 (hu) 2001-12-28
BR9911945A (pt) 2001-03-27
ITMI981586A1 (it) 2000-01-10
ITMI981586A0 (it) 1998-07-10
SK284464B6 (sk) 2005-04-01
EP1094807B1 (en) 2003-04-23
RU2003128023A (ru) 2005-04-10
CA2336990A1 (en) 2000-01-20
HUP0102781A3 (en) 2002-04-29

Similar Documents

Publication Publication Date Title
PT1094807E (pt) Vitamina e e esters para uso em tratamento local de patologias mucosas
NO20044699L (no) Vaginalpleiesammensetning
JP2004505028A5 (https=)
AR034619A1 (es) Formulaciones de olopatadine para administracion topica
AR035637A1 (es) Betamimeticos de larga accion, procedimiento para su preparacion y su empleo como medicamentos
CY1108678T1 (el) Υγρα σκευασματα για την προληψη και αντιμετωπιση βλεννογονικων νοσων και διαταραχων
DK1385519T3 (da) Tiotropiumsalte til behandling af inflammatoriske sygdomme
CA2424346A1 (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
JP2004508296A5 (https=)
MXPA05002033A (es) Una composicion farmaceutica.
BR0113927A (pt) Processos para retardar a recorrência dos sintomas de herpes vìrus
CY1106469T1 (el) Προφυλακτικο
NO20025510D0 (no) Tienodibenzoazulenforbindelser som tumor nekrose faktor inhibitorer
IS2860B (is) Veirueyðandi samsetningar
BR0206549A (pt) Uso de flumazenil na produção de uma droga para o tratamento de dependência de álcool
SE9900070D0 (sv) New use
IT1318667B1 (it) Medicamento antinfiammatorio.
DK1105141T3 (da) Phosphatidylcholin som et medikament med slimhindebeskyttende virkning
JP2005512561A5 (https=)
AR030945A1 (es) Amidas de acido fenilciclohexanocarboxilico sustituido y su uso
ITMI991144A1 (it) Acido tricloroacetico per la preparazione di soluzioni e/o composizioni per il trattamento di lesioni erosive e/o ulcerative
DE59909855D1 (de) Wirkstoff enthaltende orale oder mucosale zubereitung mit steuerbarer wirkstofffreisetzung und ihre verwendung
FR2855400B1 (fr) Dispositif rectal, notamment pour le traitement des hemorrhoides
RU2000106782A (ru) Применение препарата "юницивин" для лечения воспалительных процессов в матке женщин
UA3728U (uk) Спосіб лікування синдрому рокитанського-кюстера-майєра